Brief: Samsung Biologics’ JV Samsung Bioepis Partners With Chinese Biopharma 3SBio
07/01/2019 24:24
Jan 7 (Reuters) - Samsung Bioepis, a joint venture between
Samsung BioLogics 207940.KS and Biogen BIIB.O , in a press
release:
* SAYS FORMS PARTNERSHIP WITH CHINESE BIOPHARMA 3SBIO
Further company coverage: 207940.KS
((Reuters Messaging: joori.roh.thomsonreuters.com@reuters.net))